BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Following a pickup in butyl phenol utilisation and recovery in ATBS (acrylamido tertiary-butyl sulfonic acid) demand, Vinati Organics Ltd. reported a good Q4.
Despite its Q4 revenue growth in, full year revenue/Ebitda/profit after tax fell 7%/14%/19% YoY on less demand for ATBS.
We expect revenue/Ebitda/profit after tax to clock 34%/38%/37% compound annual growth rates over FY21-23, driven by rising demand for its products, greater utilisation of butyl phenol and a pickup in demand for ATBS.
Further, the amalgamation with Veeral would add to revenue in coming years.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.